These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7023221)

  • 1. Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
    Taylor CR; Baird JR; Blackburn KJ; Cambridge D; Constantine JW; Ghaly MS; Hayden ML; McIlhenny HM; Moore PF; Olukotun AY; Pullman LG; Salsburg DS; Saxton CA; Shevde S
    Am Heart J; 1981 Sep; 102(3 Pt 2):515-32. PubMed ID: 7023221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems in assessment of new pharmacologic agents for the heart failure patient.
    Rude RE; Grossman W; Colucci WS; Benotti JR; Carabello BA; Wynne J; Malacoff R; Braunwald E
    Am Heart J; 1981 Sep; 102(3 Pt 2):584-90. PubMed ID: 7270403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
    Aronow WS; Danahy DT
    Am J Med; 1978 Jul; 65(1):155-60. PubMed ID: 356598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of refractory congestive heart failure with prazosin.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Am Heart J; 1981 Sep; 102(3 Pt 2):626-34. PubMed ID: 6267922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance.
    Weber KT; Andrews V; Kinasewitz GT; Janicki JS; Fishman AP
    Am Heart J; 1981 Sep; 102(3 Pt 2):569-77. PubMed ID: 6115574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin.
    Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure.
    Aronow WS; Greenfield RS; Alimadadian H; Danahy DT
    Am J Cardiol; 1977 Nov; 40(5):789-93. PubMed ID: 335867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of prazosin in chronic heart failure.
    Parmley WW; Chatterjee K; Arnold S; Rubin SA; Brundage BH; Williams RL; Ports T; Chuck L; Rouleau J
    Am Heart J; 1981 Sep; 102(3 Pt 2):622-5. PubMed ID: 7270404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
    Awan NA; Needham K; Evenson MK; Hermanovich J; Joye JA; DeMaria AN; Mason DT
    Am Heart J; 1981 Sep; 102(3 Pt 2):555-63. PubMed ID: 7270402
    [No Abstract]   [Full Text] [Related]  

  • 13. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of positive inotropic and vasodilating substances in congestive heart failure.
    Cantelli I; Bracchetti D
    Cardiovasc Drugs Ther; 1988 May; 2(1):83-91. PubMed ID: 3154699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of prazosin in CHF.
    Reuben SR; Kuan P; Gale EV; Wilde PM
    Acta Med Scand Suppl; 1981; 652():145-8. PubMed ID: 6949460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
    Sharpe DN; Coxon R
    Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.
    Markham RV; Corbett JR; Gilmore A; Pettinger WA; Firth BG
    Am J Cardiol; 1983 May; 51(8):1346-52. PubMed ID: 6342353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
    Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
    Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances].
    Thormann J; Kramer W; Dieterich HA
    Herz; 1990 Jun; 15(3):190-201. PubMed ID: 2198220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
    Bayliss J; Norell M; Canepa-Anson R; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Heart J; 1983 Mar; 49(3):214-21. PubMed ID: 6830658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.